New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 27, 2012
16:15 EDTVVUS, TM, JCP, DIOD, QCOR, BCDSOn The Fly: Closing Wrap
Stocks on Wall Street spent almost the entire session in negative territory but the averages recovered most of their losses in the last hour of trading. Headlines from Washington late in the trading day indicated the House of Representatives plans a session for Sunday evening to discuss the fiscal cliff. After opening lower the averages fell to their worst levels just after midday and were trading near those levels before moving sharply higher, and eventually erasing almost all of their losses, during the final 90 minutes of trading... ECONOMIC EVENTS: In the U.S., weekly jobless claims fell 12,000 to 350,000, compared to expectations for claims to remain relatively flat with the prior week. Sales of new homes rose 4.4% in November from October to a seasonally adjusted annual rate of 377,000, beating expectations. Consumer confidence fell to its lowest level since August with a 65.1 reading for December, versus expectations for a 70.0 figure. This morning, Senate Majority Leader Harry Reid warned that there may not be enough time left to reach a budget deal and that the U.S. appears destined to head over the fiscal cliff. However, late day optimism took hold based on plans for the House to reconvene this weekend... COMPANY NEWS: U.S. listed shares of Toyota Motor (TM) gained $2.18, or 2.41%, to $92.54 after the company agreed to a settlement valued over $1B related to previous recalls over claims of accelerator pedal problems... MAJOR MOVERS: Among the notable gainers was BCD Semiconductor (BCDS), which rose $3.43, or 86.18%, to $7.41 after agreeing to be acquired by Diodes (DIOD) for $8.00 per U.S. listed share. Shares of Diodes also gained 23c, or 1.36%, to $17.14. Also higher were shares of VIVUS (VVUS), up 51c, or 3.88%, to $13.67 after the company's CEO was quoted by Financial Times as saying he foresees the potential for using direct-to-consumer advertising and a larger scale sales force to market its Qsymia weight-loss drug. Among the noteworthy losers was Questcor Pharmaceuticals (QCOR), down $2.12, or 7.09%, to $27.78 after the circulation of a Blue Cross/Blue Shield of Michigan document related to coverage of the company's Acthar Gel. Also lower were shares of and J.C. Penney (JCP), down $1.23, or 5.93%, to $19.52 after being mentioned by The Wall Street Journal as a retailer that may face a particularly challenging and important year in 2013... INDICES: The Dow was down 18.28, or 0.14%, to 13,096.31; the Nasdaq was down 4.25, or 0.14%, to 2,985.91; and the S&P 500 was down 1.74, or 0.12%, to 1,418.09.
News For TM;BCDS;DIOD;VVUS;QCOR;JCP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 1, 2015
10:32 EDTTMToyota reports June U.S. sales up 4.1% to 209,912 vehicles
Subscribe for More Information
06:47 EDTTMToyota, Nissan, Honda pushing more fuel cell vehicles on roads, AP reports
Toyota (TM), Nissan (NSANY), and Honda (HMC) are collaborating to get more fuel cell vehicles on roads in what they call Japanís push towards ďa hydrogen society,Ē the Associated Press reports. The companies pledged up to $90,000 per hydrogen station per year, including building and maintenance, the report says. Reference Link
05:31 EDTTMToyota announces resignation of Managing Officer Julie Hamp
Subscribe for More Information
June 30, 2015
15:20 EDTJCPMoody's raises J.C. Penney liquidity rating to SGL-1 from SGL-2
Moody's Investors Service revised J.C. Penney's rating outlook to positive from stable. Moody's also affirmed the company's Caa1 Corporate Family Rating, and raised the company's Speculative Grade Liquidity rating to SGL-1 from SGL-2. "The rating outlook revision to positive from stable reflects Moody's view that JC Penney's operating performance has shown signs of improvement as a result of better merchandising, cost controls, and integration of its online business" said Moody's Vice President Scott Tuhy. He added, "we have seen positive momentum building for the company to achieve $700M to $800M of adjusted EBITDA, a level in which earnings would fully cover cash flow and interest". The upgrade in the Speculative Grade Liquidity rating primarily reflects the company's improved operating performance as we expect free cash flow to be near break-even levels and the company's meaningful cash balances are sufficient to cover expected seasonal working capital needs.
June 29, 2015
14:57 EDTTMTakata asks carmakers to delay price cut requests, Nikkei says
Subscribe for More Information
June 25, 2015
10:01 EDTTMTrueCar Tprjects retail auto sales to consumers up 7.9% in June
Subscribe for More Information
07:01 EDTTMToyota, Nissan expanding air bag recalls worldwide, Reuters reports
Subscribe for More Information
June 24, 2015
17:57 EDTTMWall Street applauds Senate giving go-ahead for 'fast track' trade powers
Subscribe for More Information
10:26 EDTJCPStocks with call strike movement; TWTR JCP
Twitter (TWTR) December 40 call option implied volatility increased 1% to 44, J.C. Penney (JCP) November 20 call option implied volatility decreased 5% to 42 according to IVolatility.
June 23, 2015
10:57 EDTTMReport: Toyota offices raided by police, Globe and Mail says
Subscribe for More Information
June 22, 2015
06:08 EDTTMGeneral Motors to add over 243,000 hatcbacks to air bag recall, AP reports
Subscribe for More Information
June 19, 2015
10:50 EDTTMEPA proposes new rules for medium- and heavy-duty truck emissions
Subscribe for More Information
06:04 EDTTMToyota CEO to stand by arrested US executive Julie Hamp, Financial Times says
Toyota CEO Akio Toyoda apologized for the arrest of the company's first female western senior executive although it vowed to stand by her for now, reports the Financial Times. Toyoda commented, "Julie Hamp is an invaluable colleague... What I can do now is to believe in my colleague and co-operate fully with the investigation." Hamp was arrested on suspicion of illegally importing a prescription drug from the U.S. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use